Literature DB >> 20727467

Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital.

Klaudia Kosowska-Shick1, Kathleen G Julian, Pamela L McGhee, Peter C Appelbaum, Cynthia J Whitener.   

Abstract

We investigated emergence of linezolid resistance among coagulase-negative staphylococci at our tertiary care center in 2007. All 17 cases were healthcare associated, and prior administration of linezolid was documented <or=2 months before first isolation of linezolid-resistant coagulase-negative staphylococci for all but 1 patient. Pulse-field gel electrophoresis analysis of the 14 available strains demonstrated 1 predominant clonal type, suggesting nosocomial spread. In addition to mutations in 23S rRNA and L4 previously described, we observed novel alterations in the 23S rRNA gene (G(2215)A) and in the L3 protein (substitutions L(101)V, H(146)Q/R, F(147)I, V(154)L, M(156)T). The increase in linezolid-resistant coagulase-negative staphylococci correlated with nosocomial transmission of selected mutated strains in patients who had received linezolid.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20727467     DOI: 10.1016/j.diagmicrobio.2010.05.007

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  11 in total

Review 1.  Resistance to linezolid caused by modifications at its binding site on the ribosome.

Authors:  Katherine S Long; Birte Vester
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Mutations in the bacterial ribosomal protein l3 and their association with antibiotic resistance.

Authors:  Rasmus N Klitgaard; Eleni Ntokou; Katrine Nørgaard; Daniel Biltoft; Lykke H Hansen; Nicolai M Trædholm; Jacob Kongsted; Birte Vester
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

3.  The genetic environment of the cfr gene and the presence of other mechanisms account for the very high linezolid resistance of Staphylococcus epidermidis isolate 426-3147L.

Authors:  Jacqueline LaMarre; Rodrigo E Mendes; Teresa Szal; Stefan Schwarz; Ronald N Jones; Alexander S Mankin
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

4.  Linezolid resistance in Brazilian Staphylococcus hominis strains is associated with L3 and 23S rRNA ribosomal mutations.

Authors:  Lara M de Almeida; Maria Rita E de Araújo; Andrey G Sacramento; Mónica Pavez; Alinne G de Souza; Fernanda Rodrigues; Ana C Gales; Nilton Lincopan; Jorge L M Sampaio; Elsa M Mamizuka
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

5.  Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals.

Authors:  Rodrigo E Mendes; Lalitagauri M Deshpande; Andrew J Costello; David J Farrell
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

6.  Cfr-mediated linezolid-resistance among methicillin-resistant coagulase-negative staphylococci from infections of humans.

Authors:  Lanqing Cui; Yang Wang; Yun Li; Tao He; Stefan Schwarz; Yujing Ding; Jianzhong Shen; Yuan Lv
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

7.  Clonal dissemination of linezolid-resistant Staphylococcus capitis with G2603T mutation in domain V of the 23S rRNA and the cfr gene at a tertiary care hospital in China.

Authors:  Wanqing Zhou; Dongmei Niu; Xiaoli Cao; Mingzhe Ning; Zhifeng Zhang; Han Shen; Kui Zhang
Journal:  BMC Infect Dis       Date:  2015-02-26       Impact factor: 3.090

Review 8.  Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections.

Authors:  Olivia Ferrández; Olatz Urbina; Santiago Grau
Journal:  Drug Des Devel Ther       Date:  2016-12-22       Impact factor: 4.162

9.  In vitro activity of tedizolid against linezolid-resistant staphylococci and enterococci.

Authors:  Stephanie L Silva-Del Toro; Kerryl E Greenwood-Quaintance; Robin Patel
Journal:  Diagn Microbiol Infect Dis       Date:  2016-02-09       Impact factor: 2.803

10.  A cfr-positive clinical staphylococcal isolate from India with multiple mechanisms of linezolid-resistance.

Authors:  Vineeth Rajan; Vijay Gowdara Shankarappa Kumar; Shubha Gopal
Journal:  Indian J Med Res       Date:  2014-03       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.